Clinical Trial Update: CGM-Guided Acarbose for Painful Diabetic Neuropathy [Phase 1]

View source ↗

Summary

Phase 1 trial assessing CGM-guided dosing of acarbose for painful diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: Shifa International Hospital | Conditions: Diabetes, Diabetes Complications | Phase 1 | Status: COMPLETED